Please login to the form below

Not currently logged in
Email:
Password:

emicizumab

This page shows the latest emicizumab news and features for those working in and with pharma, biotech and healthcare.

UK’s CMA clears Roche’s $4.3bn takeover of Spark

UK’s CMA clears Roche’s $4.3bn takeover of Spark

Regulators had been scrutinising the deal because Roche’s antibody drug Hemlibra (emicizumab) has been growing at an impressive rate since its launch last year, and is firmly on course to

Latest news

More from news
Approximately 5 fully matching, plus 30 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics